Alphatec Spine Postpones 2013 Annual Meeting of Stockholders to June 21, 2013 and Supplements Proxy Statement
11 Juin 2013 - 10:05PM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a medical device company that designs,
develops, manufactures and markets physician-inspired solutions for
patients with spinal disorders, today announced that it has
postponed its 2013 Annual Meeting of Stockholders, originally
scheduled for Monday, June 17, 2013. The Annual Meeting will now
take place on Friday, June 21, 2013, at 2:00 P.M., Pacific Time at
the Company's corporate headquarters, which are located at 5818 El
Camino Real, Carlsbad, CA 92008.
The Company also announced that it has supplemented its Proxy
Statement for the 2013 Annual Meeting to add a new proposal to
approve an amendment to the Alphatec Holdings, Inc. Amended and
Restated 2005 Employee, Director and Consultant Stock Plan to
increase the per person annual award limit contained in the Plan
from 200,000 shares to 1,500,000 shares per year and to provide
additional disclosure with respect to certain other proposals in
the Proxy Statement. The Company postponed the Annual Meeting in
order to provide additional time for stockholders to review the
additional proposal and revised disclosures.
Formal notice of the rescheduled meeting, the Supplement to the
Company's Proxy Statement and new proxy cards are being mailed to
the Company's stockholders. More information on the Annual Meeting
can be found in the Company's Proxy Statement and the Supplement
thereto, which are available in the "Financial Information" section
of the "Investor Relations" section of the Company's website at
www.alphatecspine.com, and on the website of the U.S. Securities
and Exchange Commission at www.sec.gov.
The record date for the Annual Meeting has not changed as a
result of the change in the meeting date. Stockholders of record at
the close of business on April 23, 2013 are entitled to notice of,
and to vote at, the 2013 Annual Meeting and any adjournment or
postponement of the meeting. Stockholders are encouraged to
vote by telephone, the Internet or mail prior to the Annual
Meeting, whether or not they plan to attend the meeting.
Stockholders who wish to vote on the new proposal or change their
votes on the other proposals must submit a new proxy and will
revoke all prior proxies by doing so. See the information in the
Company's Proxy Statement and the Supplement thereto regarding
voting procedures.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec
Holdings, Inc., is a medical device company that designs, develops,
manufactures and markets physician-inspired products and solutions
for the treatment of spinal disorders associated with trauma,
congenital deformities, disease and degeneration. The Company's
mission is to combine innovative surgical solutions with
world-class customer service to improve outcomes and patient
quality of life. The Company and its affiliates market products in
the U.S. and in over 50 countries internationally via a direct
sales force and independent distributors. Additional information
can be found at www.alphatecspine.com.
CONTACT: Investor/Media Contact:
Mark Francois
Senior Director, Investor Relations
Alphatec Spine, Inc.
(760) 494-6610
mfrancois@AlphatecSpine.com
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024